City

Seoul (1)

Shenzhen (1)

Condition

Nilotinib (2)

CML (1)

Chronic Myeloid Leukemia, Chronic Phase (1)

Imatinib Intolerant (1)

Imatinib Resistant (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Novartis Pharmaceuticals (1)

Shenzhen Second People's Hospital (1)

Collaborator

Dongguan People's Hospital (1)

Huazhong University of Science and Technology Union Shenzhen Hospital (1)

Longgang District Central Hospital of Shenzhen (1)

The Affiliated Hospital of Guangdong Medical College (1)

Zhongshan People's Hospital, Guangdong, China (1)

Intervention

nilotinib (2)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

nilotinib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

Recruiting

Chronic Myeloid Leukemia, Chronic Phase
Nilotinib

Nilotinib

Shenzhen, Guangdong, China

Shenzhen Second People's Hospital

Mar 15, 2022

CML, Nilotinib, Imatinib Resistant Trial in Seoul (nilotinib)

Completed

CML
+3 more

nilotinib

Seoul, Korea, Republic of

St. Mary hospital, Catholic medical center

Feb 24, 2017